Pharmaceutical Sector

Pfizer raises its ‘final’ bid for AstraZeneca to £69bn

Pfizer CEO Ian Read on Sunday described the company's new proposal for AstraZeneca as "compelling" and cautioned that the American drugmaker would walk away if AstraZeneca didn't accept it.

Companies: 
General: 
People: 

Abbott agrees to acquire Latin America’s CFR Pharmaceuticals for $2.9bn

American pharmaceuticals & health care products firm Abbott Laboratories on Friday confirmed that it would acquire Chile-based CFR Pharmaceuticals SA in a $2.9 billion (£1.72 billion) deal.

Abbott will acquire nearly 73 per cent of CFR's publicly traded shares from founder Weinstein family-led holding company, while a tender offer will be issued for buying the remaining shares.

Region: 
General: 

Pfizer-AstraZeneca deal is not inevitable: Pascal Soriot

Pfizer's takeover bid for AstraZeneca is not inevitable and the Anglo-Swedish pharmaceutical giant can create value for its shareholder on its own, according to AstraZeneca CEO Pascal Soriot's claims.

Companies: 
General: 
People: 

China’ action against British executive may prompt firms to rethink their investments

Chinese police's action against a British executive of GlaxoSmithKline Plc might cause some international companies to rethink their investment plans in the country.

Region: 
Companies: 
General: 
People: 

Pfizer promises to keep British research jobs in the country

Pfizer Inc.'s chief executive Ian Read on Tuesday acknowledged that a potential takeover of AstraZeneca would lead to job losses, but it assured that the company's British research jobs would be kept in the country.

Region: 
Companies: 
General: 
People: 

Pages

Subscribe to RSS - Pharmaceutical Sector